FDA NDC Directory · JSON-LD · Markdown

GABAPENTIN

NDC 76282-321 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerExelan Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA090705
Dosage form / routeCAPSULE · ORAL
Active ingredientsGABAPENTIN (100 mg/1)
Marketing started20100426
Package count5

External sources

Source: openFDA. Public-domain (CC0).